Amundi trimmed its position in shares of The Campbell's Company (NASDAQ:CPB - Free Report) by 98.3% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,443 shares of the company's stock after selling 593,993 shares during the period. Amundi's holdings in Campbell's were worth $233,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Kornitzer Capital Management Inc. KS boosted its stake in shares of Campbell's by 1.2% during the first quarter. Kornitzer Capital Management Inc. KS now owns 42,470 shares of the company's stock valued at $946,000 after purchasing an additional 520 shares during the period. Parallel Advisors LLC increased its stake in Campbell's by 23.5% in the 1st quarter. Parallel Advisors LLC now owns 2,792 shares of the company's stock worth $62,000 after buying an additional 532 shares during the period. William B. Walkup & Associates Inc. lifted its holdings in Campbell's by 24.4% during the 1st quarter. William B. Walkup & Associates Inc. now owns 3,089 shares of the company's stock valued at $69,000 after buying an additional 605 shares in the last quarter. TD Private Client Wealth LLC lifted its holdings in Campbell's by 3.8% during the 4th quarter. TD Private Client Wealth LLC now owns 20,471 shares of the company's stock valued at $571,000 after buying an additional 745 shares in the last quarter. Finally, Resona Asset Management Co. Ltd. boosted its position in Campbell's by 39.1% in the 1st quarter. Resona Asset Management Co. Ltd. now owns 2,699 shares of the company's stock valued at $60,000 after buying an additional 759 shares during the period. 52.35% of the stock is owned by hedge funds and other institutional investors.
Campbell's Trading Down 1.0%
Shares of NASDAQ:CPB opened at $21.18 on Friday. The company has a market capitalization of $6.32 billion, a PE ratio of 16.17, a P/E/G ratio of 2.52 and a beta of 0.03. The company has a current ratio of 0.82, a quick ratio of 0.33 and a debt-to-equity ratio of 1.60. The Campbell's Company has a 12-month low of $19.56 and a 12-month high of $34.17. The business's fifty day simple moving average is $22.48 and its 200-day simple moving average is $21.93.
Campbell's (NASDAQ:CPB - Get Free Report) last issued its quarterly earnings data on Thursday, September 3rd. The company reported $0.39 earnings per share for the quarter, meeting analysts' consensus estimates of $0.39. Campbell's had a return on equity of 16.44% and a net margin of 4.04%.The company had revenue of $2.14 billion for the quarter. During the same period in the previous year, the business earned $0.62 EPS. Campbell's's revenue for the quarter was down 7.9% compared to the same quarter last year. Campbell's has set its FY 2027 guidance at 1.650-1.800 EPS. As a group, equities research analysts predict that The Campbell's Company will post 1.7 earnings per share for the current fiscal year.
Campbell's Cuts Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, November 2nd. Shareholders of record on Thursday, October 1st will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 4.7%. The ex-dividend date is Thursday, October 1st. Campbell's's dividend payout ratio (DPR) is 119.08%.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on CPB shares. Sanford C. Bernstein restated an "underperform" rating and issued a $19.00 target price (down from $21.00) on shares of Campbell's in a research note on Tuesday, June 9th. DA Davidson reaffirmed a "neutral" rating and set a $20.00 price target on shares of Campbell's in a research note on Tuesday, September 8th. Morgan Stanley lowered their price target on Campbell's from $23.00 to $21.00 and set an "equal weight" rating for the company in a report on Friday, June 5th. Barclays dropped their price objective on Campbell's from $19.00 to $18.00 and set an "underweight" rating on the stock in a research note on Friday, September 4th. Finally, JPMorgan Chase & Co. lifted their target price on Campbell's from $20.00 to $22.00 and gave the company a "neutral" rating in a research report on Tuesday, August 18th. Twelve equities research analysts have rated the stock with a Hold rating and seven have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Campbell's has an average rating of "Reduce" and an average target price of $19.88.
Get Our Latest Report on CPB
Campbell's Profile
(
Free Report)
Campbell's NASDAQ: CPB is a branded food company that develops, produces and markets packaged meals, beverages and snacks. Its portfolio includes soups, sauces, pasta products, frozen meals, dips, crackers, cookies and yogurt.
The company's brands include Campbell's, Goldfish, Pepperidge Farm, V8, Prego, Pace, Swanson, Rao's, Michael Angelo's and noosa. Products are sold primarily through grocery stores, mass merchants, club stores, convenience stores, food-service distributors and e-commerce channels.
Founded in 1869 by Joseph A.
Featured Articles
Want to see what other hedge funds are holding CPB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Campbell's Company (NASDAQ:CPB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Campbell's, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Campbell's wasn't on the list.
While Campbell's currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.